Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

AnaSpec Introduces Extensive Line of Caspase Substrates and Inhibitors

Released on = September 5, 2006, 4:58 pm

Press Release Author = Debra Thai

Industry = Biotech

Press Release Summary = Caspases are a family of cysteine-dependent aspartate
specific proteases involved in the destruction of cells. In a normal, healthy human
being, damaged or mutated cells are regularly destroyed to protect the rest of the
body.

Press Release Body = The induction of caspase-dependent programmed cell death
triggers a tightly-controlled cascade of events with the initiator caspases
activating effector caspases. These effector caspases not only activate other
effector caspases and provide feedback to initiator caspases, they also cleave
cellular substrates resulting in morphological changes such as DNA fragmentation,
membrane blebbing or apoptotic body formation. These changes, characteristics of
apoptosis, ultimately lead to the death of a cell. Caspases, however, may not be the
only enzymes involved in cell death; cell death may still occur even if all caspases
are all blocked (Reviewed in 1).

Because of their important role in apoptosis and cell signaling, and their
identification as drug-screening targets, there is a recognized need for a wide
range of caspase substrates and inhibitors. As a leading provider of premium quality
peptides and detection reagents, AnaSpec has introduced an extensive list of caspase
substrates (including both chromogenic and fluorogenic variations) and caspase
inhibitors.

For additional information, visit www.anaspec.com

Reference:
1. Thornberry, NA. and Y. Lazebnik, Science 281, 1312-1316 (1998).



Web Site = http://www.anaspec.com

Contact Details = 2149 O\'toole Ave.
San Jose, CA 95131
Tel: 408-452-5055
Fax: 408-452-5059
marketing@anaspec.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •